BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11159883)

  • 21. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
    Toyoshima H; Hunter T
    Cell; 1994 Jul; 78(1):67-74. PubMed ID: 8033213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of G(1)/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1.
    Clark E; Santiago F; Deng L; Chong S; de La Fuente C; Wang L; Fu P; Stein D; Denny T; Lanka V; Mozafari F; Okamoto T; Kashanchi F
    J Virol; 2000 Jun; 74(11):5040-52. PubMed ID: 10799578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency.
    Lane HA; Beuvink I; Motoyama AB; Daly JM; Neve RM; Hynes NE
    Mol Cell Biol; 2000 May; 20(9):3210-23. PubMed ID: 10757805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.
    Blain SW; Montalvo E; Massagué J
    J Biol Chem; 1997 Oct; 272(41):25863-72. PubMed ID: 9325318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).
    Groshong SD; Owen GI; Grimison B; Schauer IE; Todd MC; Langan TA; Sclafani RA; Lange CA; Horwitz KB
    Mol Endocrinol; 1997 Oct; 11(11):1593-607. PubMed ID: 9328342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.
    Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA
    Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ; Higgins T; Jones NC; Rozengurt E
    Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin E-CDK2 is a regulator of p27Kip1.
    Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE
    Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dependence of cyclin E-CDK2 kinase activity on cell anchorage.
    Fang F; Orend G; Watanabe N; Hunter T; Ruoslahti E
    Science; 1996 Jan; 271(5248):499-502. PubMed ID: 8560263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells.
    Brugarolas J; Bronson RT; Jacks T
    J Cell Biol; 1998 Apr; 141(2):503-14. PubMed ID: 9548727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21(waf1/cip1) and p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells.
    Frey MR; Saxon ML; Zhao X; Rollins A; Evans SS; Black JD
    J Biol Chem; 1997 Apr; 272(14):9424-35. PubMed ID: 9083081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin E-mediated elimination of p27 requires its interaction with the nuclear pore-associated protein mNPAP60.
    Müller D; Thieke K; Bürgin A; Dickmanns A; Eilers M
    EMBO J; 2000 May; 19(10):2168-80. PubMed ID: 10811608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression.
    Jiang H; Chou HS; Zhu L
    Mol Cell Biol; 1998 Sep; 18(9):5284-90. PubMed ID: 9710613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New functional activities for the p21 family of CDK inhibitors.
    LaBaer J; Garrett MD; Stevenson LF; Slingerland JM; Sandhu C; Chou HS; Fattaey A; Harlow E
    Genes Dev; 1997 Apr; 11(7):847-62. PubMed ID: 9106657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a).
    Mitra J; Dai CY; Somasundaram K; El-Deiry WS; Satyamoorthy K; Herlyn M; Enders GH
    Mol Cell Biol; 1999 May; 19(5):3916-28. PubMed ID: 10207115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome.
    Nguyen H; Gitig DM; Koff A
    Mol Cell Biol; 1999 Feb; 19(2):1190-201. PubMed ID: 9891053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo.
    Shankland SJ; Floege J; Thomas SE; Nangaku M; Hugo C; Pippin J; Henne K; Hockenberry DM; Johnson RJ; Couser WG
    Kidney Int; 1997 Aug; 52(2):404-13. PubMed ID: 9263996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression.
    Radeva G; Petrocelli T; Behrend E; Leung-Hagesteijn C; Filmus J; Slingerland J; Dedhar S
    J Biol Chem; 1997 May; 272(21):13937-44. PubMed ID: 9153256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.